Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Sclerotherapy  





2 References  














Polidocanol






العربية
Español
Magyar
Nederlands

ି
Polski
Português
Русский
Српски / srpski
Srpskohrvatski / српскохрватски
Tiếng Vit
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Polidocanol
Clinical data
Other names 
  • Polydocanol
  • Laureth 9
  • Macrogol lauryl ether
  • Lauromacrogol
  • PEG-9 lauryl alcohol
  • POE-9 lauryl alcohol
  • Dodecylpolyethyleneglycolether
  • Hydroxyl polyethoxy dodecane
  • Oxypolyethoxydodecane
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • Topical: allowed
    Injection: contraindication in months 1–3 and after week 36
Routes of
administration
topical, subcutaneous injection
ATC code
Legal status
Legal status
  • OTC (topical), Rx (injection)
  • Identifiers
    • 3,6,9,12,15,18,21,24,27-nonaoxanonatriacontan-1-ol

    CAS Number
    PubChem CID
    ChemSpider
    UNII
    KEGG
    ChEMBL
    CompTox Dashboard (EPA)
    ECHA InfoCard100.019.351 Edit this at Wikidata
    Chemical and physical data
    FormulaC30H62O10
    Molar mass582.816 g·mol−1
    3D model (JSmol)
    • CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

    • InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3 ☒N

    • Key:ONJQDTZCDSESIW-UHFFFAOYSA-N ☒N

     ☒NcheckY (what is this?)  (verify)

    Polidocanol is a local anaesthetic and antipruritic component of ointments and bath additives. It relieves itching caused by eczema and dry skin.[2] It has also been used to treat varicose veins,[3] hemangiomas, and vascular malformations.[4] It is formed by the ethoxylationofdodecanol.

    Sclerotherapy[edit]

    Polidocanol is also used as a sclerosant, an irritant injected to treat varicose veins, under the trade names Asclera, Aethoxysklerol[5] and Varithena.[6] Polidocanol causes fibrosis inside varicose veins, occluding the lumen of the vessel, and reducing the appearance of the varicosity.

    The FDA has approved polidocanol injections for the treatment of small varicose (less than 1 mm in diameter) and reticular veins (1 to 3 mm in diameter). Polidocanol works by damaging the cell lining of blood vessels, causing them to close and eventually be replaced by other types of tissue.[7][8] Polidocanol in the form of Varithena injected in the greater saphenous vein can cause the eruption of varicose and spider veins throughout the lower leg. This procedure should be done with caution and with the knowledge that the appearance of the leg may be forever compromised.

    Pure polidocanol for pharmaceutical use

    References[edit]

    1. ^ "Health Canada New Drug Authorizations: 2015 Highlights". Health Canada. 4 May 2016. Retrieved 7 April 2024.
  • ^ "E45 itch relief cream". netdoctor.co.uk. Retrieved 2007-07-12.
  • ^ Star P, Connor DE, Parsi K (April 2018). "Novel developments in foam sclerotherapy: Focus on Varithena (polidocanol endovenous microfoam) in the management of varicose veins". Phlebology. 33 (3): 150–162. doi:10.1177/0268355516687864. PMID 28166694.
  • ^ Gao Z, Zhang Y, Li W, Shi C (January 2018). "Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis". Dermatologic Therapy. 31 (1). doi:10.1111/dth.12568. PMID 29082587.
  • ^ Sclerotherapy, Laurence Z Rosenberg, MD, eMedicine.com
  • ^ "Varithena (polidocanol injectable foam) For Intravenous Use. Full Prescribing Information" (PDF). Biocompatibles, Inc. Archived from the original (PDF) on 4 August 2016. Retrieved 1 October 2015.
  • ^ Facts and Companies: Varicose Vein Treatment Approved
  • ^ "Asclera Full Prescribing Information in Drug Reference Encyclopedia". Retrieved 2010-04-11.

  • t
  • e
  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Polidocanol&oldid=1217675312"

    Categories: 
    Fatty alcohols
    Polyethers
    Polymers
    Antipruritics
    Vascular surgery
    Non-ionic surfactants
    Cardiovascular system drug stubs
    Dermatologic drug stubs
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Drugs with non-standard legal status
    Articles with changed ChemSpider identifier
    Articles with changed EBI identifier
    ECHA InfoCard ID from Wikidata
    Articles with changed InChI identifier
    Chemical pages without DrugBank identifier
    Drugboxes which contain changes to verified fields
    Drugboxes which contain changes to watched fields
    All stub articles
     



    This page was last edited on 7 April 2024, at 06:13 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki